Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene delivery using herpes simplex virus vectors.

Edward A Burton1, David J Fink, Joseph C Glorioso

  • 1Department of Clinical Neurology, University of Oxford, United Kingdom.

DNA and Cell Biology
|February 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional interrogation of neuronal connections by chemoptogenetic presynaptic ablation.

Science advances·2026
Same author

Correction: Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications.

Gene therapy·2026
Same author

An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma.

Molecular therapy. Oncology·2025
Same author

The pesticide chlorpyrifos increases the risk of Parkinson's disease.

Molecular neurodegeneration·2025
Same author

[Importance of vision in old age].

Zeitschrift fur Gerontologie und Geriatrie·2025
Same author

Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications.

Gene therapy·2025

Herpes simplex virus (HSV) vectors offer efficient gene delivery for various diseases. These non-pathogenic vectors enable long-term transgene expression, showing promise in pre-clinical neurological disease models.

Area of Science:

  • Virology
  • Gene Therapy
  • Neuroscience

Background:

  • Herpes simplex virus (HSV) is a neurotropic DNA virus with inherent properties suitable for gene delivery.
  • HSV vectors are highly infectious, facilitating efficient delivery of genetic material to cells.
  • Viral replication can be disrupted, allowing for the production of non-pathogenic, high-titer vectors.

Purpose of the Study:

  • To explore the potential of HSV as a gene delivery vector.
  • To highlight the advantages of HSV vectors for therapeutic applications.
  • To review pre-clinical findings and future clinical potential.

Main Methods:

  • Utilizing replication-defective HSV vectors.
  • Engineering vectors for stable transgene expression.

Related Experiment Videos

  • Exploiting latency-associated promoters for long-term expression.

    • Main Results:

    • HSV vectors demonstrate efficient gene delivery and broad tissue tropism.
    • Replication-defective vectors establish non-pathogenic, persistent infections.
    • Pre-clinical studies show encouraging results in neurological disease models.

    Conclusions:

    • HSV vectors are promising tools for gene therapy, particularly in neurological disorders.
    • Their ability to persist and express transgenes long-term makes them suitable for treating conditions like glioma and neurodegeneration.
    • HSV vectors are advancing towards clinical trials for various therapeutic applications.